Status:
COMPLETED
Evaluation of Carbohydrates
Lead Sponsor:
Abbott Nutrition
Conditions:
Glycemic Index
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The study is open-label with a randomized, cross-over design using standard Gl methodology.
Eligibility Criteria
Inclusion
- Subjects are males or non-pregnant females in good health.
- Subjects must be eligible to receive income in Canada and must demonstrate OHIP or equivalent medical coverage.
Exclusion
- Subject with any type of food allergy or with a known history of AIDS, hepatitis, diabetes or a heart condition.
- Subject taking medication, or with any condition which might, in the opinion of the PI either make participation dangerous to the subject or to others or affect the results.
Key Trial Info
Start Date :
July 17 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2017
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03242122
Start Date
July 17 2017
End Date
August 18 2017
Last Update
September 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Glycemic Index Laboratories Inc
Toronto, Ontario, Canada, M5C 2N8